Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.

RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer.

Porkka KP, Tammela TL, Vessella RL, Visakorpi T.

Genes Chromosomes Cancer. 2004 Jan;39(1):1-10.

PMID:
14603436
2.

High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer.

van Duin M, van Marion R, Vissers K, Watson JE, van Weerden WM, Schröder FH, Hop WC, van der Kwast TH, Collins C, van Dekken H.

Genes Chromosomes Cancer. 2005 Dec;44(4):438-49.

PMID:
16130124
3.

Amplification and overexpression of Elongin C gene discovered in prostate cancer by cDNA microarrays.

Porkka K, Saramäki O, Tanner M, Visakorpi T.

Lab Invest. 2002 May;82(5):629-37.

PMID:
12004003
4.

Amplification of hypoxia-inducible factor 1alpha gene in prostate cancer.

Saramäki OR, Savinainen KJ, Nupponen NN, Bratt O, Visakorpi T.

Cancer Genet Cytogenet. 2001 Jul 1;128(1):31-4.

PMID:
11454426
5.

Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays.

Bubendorf L, Kolmer M, Kononen J, Koivisto P, Mousses S, Chen Y, Mahlamäki E, Schraml P, Moch H, Willi N, Elkahloun AG, Pretlow TG, Gasser TC, Mihatsch MJ, Sauter G, Kallioniemi OP.

J Natl Cancer Inst. 1999 Oct 20;91(20):1758-64.

6.

Overexpression and gene amplification of BAG-1L in hormone-refractory prostate cancer.

Mäki HE, Saramäki OR, Shatkina L, Martikainen PM, Tammela TL, van Weerden WM, Vessella RL, Cato AC, Visakorpi T.

J Pathol. 2007 Aug;212(4):395-401.

PMID:
17503439
7.

Screening of genetic and expression alterations of SRC1 gene in prostate cancer.

Mäki HE, Waltering KK, Wallén MJ, Martikainen PM, Tammela TL, van Weerden WM, Vessella RL, Visakorpi T.

Prostate. 2006 Sep 15;66(13):1391-8.

PMID:
16894533
8.

Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.

Chakrabarti R, Robles LD, Gibson J, Muroski M.

Cancer Genet Cytogenet. 2002 Dec;139(2):115-25.

PMID:
12550771
9.

Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer.

Savinainen KJ, Linja MJ, Saramäki OR, Tammela TL, Chang GT, Brinkmann AO, Visakorpi T.

Br J Cancer. 2004 Mar 8;90(5):1041-6.

10.

Haploinsufficiency and reduced expression of genes localized to the 8p chromosomal region in human prostate tumors.

Chaib H, MacDonald JW, Vessella RL, Washburn JG, Quinn JE, Odman A, Rubin MA, Macoska JA.

Genes Chromosomes Cancer. 2003 Jul;37(3):306-13.

11.

Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis.

Bärlund M, Forozan F, Kononen J, Bubendorf L, Chen Y, Bittner ML, Torhorst J, Haas P, Bucher C, Sauter G, Kallioniemi OP, Kallioniemi A.

J Natl Cancer Inst. 2000 Aug 2;92(15):1252-9.

12.

Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer.

Linja MJ, Savinainen KJ, Saramäki OR, Tammela TL, Vessella RL, Visakorpi T.

Cancer Res. 2001 May 1;61(9):3550-5.

14.

Identification of differentially expressed genes in human prostate cancer using subtraction and microarray.

Xu J, Stolk JA, Zhang X, Silva SJ, Houghton RL, Matsumura M, Vedvick TS, Leslie KB, Badaro R, Reed SG.

Cancer Res. 2000 Mar 15;60(6):1677-82.

15.

Mapping the amplification of EIF3S3 in breast and prostate cancer.

Nupponen NN, Isola J, Visakorpi T.

Genes Chromosomes Cancer. 2000 Jun;28(2):203-10.

PMID:
10825005
16.

Identification of overexpressed genes in frequently gained/amplified chromosome regions in multiple myeloma.

Largo C, Alvarez S, Saez B, Blesa D, Martin-Subero JI, González-García I, Brieva JA, Dopazo J, Siebert R, Calasanz MJ, Cigudosa JC.

Haematologica. 2006 Feb;91(2):184-91.

17.

Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform.

Tsuda H, Birrer MJ, Ito YM, Ohashi Y, Lin M, Lee C, Wong WH, Rao PH, Lau CC, Berkowitz RS, Wong KK, Mok SC.

Cancer Genet Cytogenet. 2004 Dec;155(2):97-107.

PMID:
15571795
18.

Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell lines.

Hermans KG, van Alewijk DC, Veltman JA, van Weerden W, van Kessel AG, Trapman J.

Genes Chromosomes Cancer. 2004 Mar;39(3):171-84.

PMID:
14732919
19.

Cloning and characterization of UROC28, a novel gene overexpressed in prostate, breast, and bladder cancers.

An G, Ng AY, Meka CS, Luo G, Bright SP, Cazares L, Wright GL Jr, Veltri RW.

Cancer Res. 2000 Dec 15;60(24):7014-20.

20.

Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q.

Orsetti B, Nugoli M, Cervera N, Lasorsa L, Chuchana P, Rougé C, Ursule L, Nguyen C, Bibeau F, Rodriguez C, Theillet C.

Br J Cancer. 2006 Nov 20;95(10):1439-47.

Items per page

Supplemental Content

Support Center